HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

carcinine

structure
Also Known As:
beta-alanylhistamine
Networked: 20 relevant articles (2 outcomes, 7 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Babizhayev, Mark A: 13 articles (04/2015 - 01/2010)
2. Yegorov, Yegor E: 8 articles (04/2015 - 01/2010)
3. Lankin, Vadim Z: 3 articles (04/2015 - 10/2012)
4. Savel'yeva, Ekaterina L: 3 articles (04/2015 - 11/2011)
5. Vishnyakova, Khava S: 3 articles (03/2015 - 01/2014)
6. Kasus-Jacobi, Anne: 2 articles (01/2014 - 10/2012)
7. Deyev, Anatoliy I: 2 articles (12/2013 - 10/2012)
8. Chaturvedi, Ratna: 1 article (03/2016)
9. Guo, Peiyi: 1 article (03/2016)
10. Li, Hong-Sheng: 1 article (03/2016)

Related Diseases

1. Eye Diseases (Eye Disease)
03/01/2015 - "The preliminary longitudinal studies of elderly individuals suggest that longer telomeres are associated with better survival, and an advanced oral nutritional support with nonhydrolyzed carnosine (or carcinine and patented compositions thereof) is a useful therapeutic tool for a critical TL maintenance that may fundamentally be applied in the treatment of age-related sight-threatening eye disorders, prolonged life expectancy, increased survival and chronological age of an organism in health control, smoking behavior, and disease. "
10/01/2012 - "The discovery of naturally occurring carnosine derivatives introduces N-acetylcarnosine and carcinine as effective medical treatment for sight-threatening eye disorders."
01/01/2014 - "The preliminary longitudinal studies of elderly individuals suggest that longer telomeres are associated with better survival and an advanced oral nutritional support with non-hydrolyzed carnosine (or carcinine and patented compositions thereof) and patented N-acetylcarnosine lubricant eye drops are useful therapeutic tools of a critical telomere length maintenance that may fundamentally be applied in the treatment of age-related sight-threatening eye disorders, prolong life expectancy, increase survival and chronological age of an organism in health control, smoking behavior and disease. "
07/01/2011 - "A growing evidence is presented that demonstrates the ability of NAC (lubricant eye drops) or carcinine to act as pharmacological chaperones, or being synergistically coupled in patented formulations with another imidazole-containing peptidomimetic (such as, Leucyl-histidylhydrazide), to decrease oxidative stress and ameliorate oxidative and excessive glycation stress-related eye disease phenotypes, suggesting that the field of chaperone therapy might hold novel treatments for age-related cataracts, glaucoma, age-related macular degeneration (AMD), and ocular complications of diabetes (OCD). "
08/01/2012 - "A growing evidence and discussion of recent patents are presented in this study that demonstrate the ability of N-acetylcarnosine (lubricant eye drops) or carcinine (lubricant eye drops) (universal antioxidant and deglycation agent) resistant to enzymatic hydrolysis with carnosinase to act as pharmacological chaperones, to decrease oxidative stress and ameliorate oxidative and excessive glycation stress-related eye disease phenotypes, suggesting that the field of chaperone therapy might hold novel treatments for age-related cataracts, age-related macular degeneration (AMD) and ocular complications of diabetes (OCD). "
2. Epilepsy (Aura)
3. Metabolic Syndrome (Dysmetabolic Syndrome X)
4. Cognitive Dysfunction
5. Sarcopenia

Related Drugs and Biologics

1. Carnosine
2. Histamine H3 Receptors (Histamine H3 Receptor)
3. Telomerase (Telomerase Reverse Transcriptase)
4. N-acetylcarnosine
5. imidazole
6. Antioxidants
7. Lubricant Eye Drops (Artificial Tears)
8. Dipeptides
9. Prodrugs
10. Imidazoles

Related Therapies and Procedures

1. Therapeutics
2. Nutritional Support (Artificial Feeding)
3. Intravitreal Injections